Cormedix Inc (CRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,433 | -26,830 | -33,010 | -24,644 | -18,188 |
| Depreciation Amortization | 386 | 74 | 37 | 26 | 15 |
| Accounts receivable | 11 | 52 | -48 | 308 | -248 |
| Accounts payable and accrued liabilities | -1,564 | 782 | 158 | -64 | 825 |
| Other Working Capital | -1,934 | 1,944 | 2,877 | 888 | 599 |
| Other Operating Activity | 4,483 | 277 | 1,399 | 1,221 | 4,470 |
| Operating Cash Flow | $-15,052 | $-23,701 | $-28,587 | $-22,265 | $-12,527 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -11,984 | 1,604 | 10,510 | 11,479 | -23,593 |
| PPE Investments | -37 | -49 | -152 | -59 | -15 |
| Investing Cash Flow | $-12,021 | $1,555 | $10,358 | $11,420 | $-23,608 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 7,500 | N/A | N/A | N/A |
| Common Stock Issued | 24,031 | 22,006 | 18,648 | 7,093 | 43,603 |
| Other Financing Activity | 1,773 | -109 | 1,877 | 0 | 27 |
| Financing Cash Flow | $25,804 | $29,397 | $20,525 | $7,093 | $43,630 |
| Exchange Rate Effect | -2 | -8 | 20 | 0 | -17 |
| Beginning Cash Position | 17,795 | 10,551 | 8,236 | 11,817 | 4,340 |
| End Cash Position | 16,525 | 17,795 | 10,551 | 8,065 | 11,817 |
| Net Cash Flow | $-1,270 | $7,244 | $2,315 | $-3,753 | $7,478 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,052 | -23,701 | -28,587 | -22,265 | -12,527 |
| Capital Expenditure | -37 | -49 | -152 | -59 | -15 |
| Free Cash Flow | -15,089 | -23,750 | -28,739 | -22,324 | -12,542 |